18:02 IST
BSE
Management Change
Bal Pharma Management Change
Bal Pharma Limited announced a change in designations for directors Ravindra Kumar Kothari and Virupakshaya Himesh, effective October 1, 2026.
Bal Pharma Ltd
- Share price
- ₹97.50
- Market cap
- ₹155.2 Cr
- Revenue (annual)
- ₹311.7 Cr
- Net profit (annual)
- ₹6.28 Cr
- P/E (TTM)
- 21.5×Sector 47.4×
- Promoter holding
- 50.86%+0.00% QoQ
- FII holding
- 0.15%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
All
Annual General Meeting 7Other Announcement 4Capital Structure Change 3Management Change 2Price Movement Clarification 1Merger & Restructuring 1Financial Results 1Dividend 1Board Meeting Date 1Annual Report 1
Time
2 announcements with these filters
18:38 IST
BSE
Management Change
Bal Pharma Management Change
Bal Pharma Limited announced changes in director designations, effective October 1, 2026. These changes were approved during the board meeting held on August 12, 2026.